Evidence map›Paper›PMID 38799753›Full record

ArticleHeliyon2024

High-yield fabrication of monodisperse multilayer nanofibrous microparticles for advanced oral drug delivery applications.

Fatemeh Ajalloueian, Lasse Højlund Eklund Thamdrup, Chiara Mazzoni, Ritika Singh Petersen, Stephan Sylvest Keller, Anja Boisen

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fatemeh AjalloueianDepartment of Health Technology, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.
Lasse Højlund Eklund ThamdrupDepartment of Health Technology, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.
Chiara MazzoniDepartment of Health Technology, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.
Ritika Singh PetersenNational Centre for Nano Fabrication and Characterization, DTU Nanolab, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.
Stephan Sylvest KellerNational Centre for Nano Fabrication and Characterization, DTU Nanolab, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.
Anja BoisenDepartment of Health Technology, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in the use of nano- and microparticles in drug delivery, cell therapy, and tissue engineering have led to increasing attention towards nanostructured microparticulate formulations for maximum benefit from both nano- and micron sized features. Scalable manufacturing of monodisperse nanostructured microparticles with tunable size, shape, content, and release rate remains a big challenge. Current technology, mainly comprises complex multi-step chemical procedures with limited control over these aspects. Here, we demonstrate a novel technique for high-yield fabrication of monodisperse monolayer and multilayer nanofibrous microparticles (MoNami and MuNaMi respectively). The fabrication procedure includes sequential electrospinning followed by micro-cutting at room temperature and transfer of particles for collection. The big advantage of the introduced technique is the potential to apply several polymer-drug combinations forming multilayer microparticles enjoying extracellular matrix (ECM)-mimicking architecture with tunable release profile. We demonstrate the fabrication and study the factors affecting the final three-dimensional structure. A model drug is encapsulated into a three-layer sheet (PLGA-pullulan-PLGA), and we demonstrate how the release profile changes from burst to sustain by simply cutting particles out of the electrospun sheet. We believe our fabrication method offers a unique and facile platform for realizing advanced microparticles for oral drug delivery applications.

Indexed as

CompactnessMicro-cuttingMultilayer nanofibrous microparticlesOral drug deliverySequential electrospinningTunable release

Identifiers

PMID38799753
PMCPMC11126835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.